$TNXP
-
Markets
Tonix Pharmaceuticals Reports Phase 3 Results for TNX-102 SL in Fibromyalgia Treatment
$TNXP Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is making significant strides in the field of pain management, unveiling encouraging clinical…
Read More » -
Markets
Tonix Pharmaceuticals Makes Progress on Fibromyalgia Treatment and Grows Its Drug Pipeline
$TNXP Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) has shared its latest financial results and outlined recent progress across several key…
Read More »